Canary Capital has submitted itself to the US Securities and Exchange Commission to launch the very first Studs-Injectief (Into-Injective-treated Fund (Inne), with the aim of offering institutional investors regulated access to native returns on the chain.
The proposed Canary Stusted Inj ETF would actively focus on the injective proof-of-stake network, which transmits rewards, currently estimated at 10% to 12% per year, directly to shareholders.
It also means the growing market confidence in the Injective ecosystem, which has attracted strategic support from companies such as Google Cloud and T-Mobile.
Injective Labs is also actively involved in continuous discussions with American supervisors to define conforming paths for decentralized finances.
Wider ETF strategy
The Inj ETF is part of a larger push from Canary Capital, a company led by former Valkyrie Cio Steven McClurg, to bring digital assets with a high return in traditional market structures.
Canary has already submitted ETFs to Solana, XRP, Hedera, Sui and the Pudgy Penguins NFT project. Several of these applications include setting components, such as the marinade-driven Solana ETF, which positions the company as a leader in setting up built-in investment products.
Canary has set up a legal confidence in Delaware to support the Inj Fund, with a reflection of its earlier archives and signaling intention to meet the evolving expectations of the SEC about storage, selection of validators and revenue treatment.
The proposal lands during Crypto Week 2025, since legislators are debating several accounts that could define the legal framework for deportation and other crypto-native activities. With SEC leadership now more open for structured yield products, the timing of Canary reflects a calculated bet on a legal shift.
Different issues want to record incoming ETFs. Some have also submitted to activate the setting for Spot Ethereum ETFs that are already live, including BlackRock.
